当前位置:首页 - 行情中心 - 伟思医疗(688580) - 财务分析 - 现金流量表

伟思医疗

(688580)

  

流通市值:50.76亿  总市值:50.76亿
流通股本:9577.13万   总股本:9577.13万

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金366,019,861.6236,082,962.93107,027,073.4458,474,244.49
  收到的税费返还13,420,143.328,203,831.733,264,164.4615,517,933.67
  收到其他与经营活动有关的现金10,738,740.269,615,078.066,762,350.6723,570,795.28
  经营活动现金流入小计390,178,745.18253,901,872.72117,053,588.53497,562,973.44
  购买商品、接受劳务支付的现金96,804,106.5461,510,302.0330,805,575.94115,189,768.63
  支付给职工以及为职工支付的现金108,426,858.9475,991,713.2243,783,368.47151,363,091.5
  支付的各项税费40,509,905.2929,099,421.9711,602,116.8260,040,712.75
  支付其他与经营活动有关的现金40,031,622.9722,515,471.798,459,886.9452,681,770
  经营活动现金流出的平衡项目0000.01
  经营活动现金流出小计285,772,493.74189,116,909.0194,650,948.17379,275,342.89
  经营活动产生的现金流量净额104,406,251.4464,784,963.7122,402,640.36118,287,630.55
二、投资活动产生的现金流量:
  收回投资收到的现金2,591,000,0001,681,000,000791,000,0002,795,000,000
  取得投资收益收到的现金9,763,745.786,593,169.163,126,773.5111,336,994.51
  处置固定资产、无形资产和其他长期资产收回的现金净额44044044022,530
  收到的其他与投资活动有关的现金1,761,0001,200,000150,000900,000
  投资活动现金流入小计2,602,525,185.781,688,793,609.16794,277,213.512,807,259,524.51
  购建固定资产、无形资产和其他长期资产支付的现金86,592,384.9254,350,575.5334,866,799.39113,075,847.21
  投资支付的现金2,591,000,0001,681,000,000791,000,0002,795,000,000
  支付其他与投资活动有关的现金1,150,0001,000,000--
  投资活动现金流出小计2,678,742,384.921,736,350,575.53825,866,799.392,908,075,847.21
  投资活动产生的现金流量净额-76,217,199.14-47,556,966.37-31,589,585.88-100,816,322.7
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金---13,321,999.6
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---13,321,999.6
  分配股利、利润或偿付利息支付的现金77,571,632.1477,237,024.02-102,196,467.99
  支付其他与筹资活动有关的现金434,480.43146,162.66-15,194,315.84
  筹资活动现金流出平衡项目00-0
  筹资活动现金流出小计78,006,112.5777,383,186.68-117,390,783.83
  筹资活动产生的现金流量净额平衡项目00-0
  筹资活动产生的现金流量净额-78,006,112.57-77,383,186.68--104,068,784.23
四、汇率变动对现金及现金等价物的影响14,187.894,022.12-575.693,281.4
五、现金及现金等价物净增加额-49,802,872.38-60,151,167.22-9,187,521.21-86,594,194.98
  加:期初现金及现金等价物余额1,067,206,832.731,067,206,832.731,067,206,832.731,153,801,027.71
  期末现金及现金等价物余额1,017,403,960.351,007,055,665.511,058,019,311.521,067,206,832.73
补充资料:
  净利润-69,324,242.51-101,969,230.54
  资产减值准备---29,234.54
  固定资产和投资性房地产折旧-6,657,647.73-12,005,868.19
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-6,657,647.73-12,005,868.19
  无形资产摊销-7,894,032.23-8,714,699.4
  长期待摊费用摊销-626,434-1,430,486.9
  处置固定资产、无形资产和其他长期资产的损失-864.63--3,909.66
  固定资产报废损失---12,183.08
  公允价值变动损失----2,419,469.21
  财务费用-701,883.15-1,308,733.32
  投资损失--6,593,169.16--11,336,994.51
  递延所得税--526,161.52-832,211.41
  其中:递延所得税资产减少--493,173.02-898,487.03
    递延所得税负债增加--32,988.5--66,275.62
  存货的减少--2,810,874.76-1,149,861.74
  经营性应收项目的减少--1,694,589.33-7,765,045.27
  经营性应付项目的增加--9,706,372.4--9,170,778.14
  其他---3,470,409.79
  不涉及现金收支的投资和筹资活动金额其他项目-7,321.95-3,101,294.96
  现金的期末余额-1,007,055,665.51-1,067,206,832.73
  减:现金的期初余额-1,067,206,832.73-1,153,801,027.71
  现金及现金等价物的净增加额--60,151,167.22--86,594,194.98
公告日期2025-10-232025-08-282025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑